COVID Resource Center Newsroom

Saliva testing has emerged as a viable option for obtaining rapid, reliable test results during the COVID-19 pandemic. Mayo Clinic’s Dr. Darci Block considers how this type of testing may expand beyond the pandemic, and the obstacles in its way.

Of five articles listed among the Journal of Clinical Microbiology’s “Top Cited” collection from the last two years, three included Mayo Clinic authors with papers focused on SARS-CoV-2.

As a regular contributor to Forbes regarding COVID-19, Dr. Matthew Binnicker offers expert health information to help people better understand the ever-changing nature of the pandemic.

On this week’s episode of the "Answers From the Lab" podcast, Bobbi Pritt, M.D., is joined by Matthew Binnicker, Ph.D., chair of Mayo Clinic’s Division of Clinical Microbiology. Dr. Pritt and Dr. Binnicker discuss the current state of laboratory testing for COVID-19 amid the omicron surge, as well the status of testing for other common respiratory viruses, including influenza.

Dr. William Morice II, president of Mayo Clinic Laboratories, named among the publication’s list of influencers, thought leaders, and key players driving change in the year ahead.

If you need a test for COVID-19, a variety of options are now available. But how do you know which one is right for you? Use this guide from Mayo Clinic Laboratories to sort through the choices and help you decide.

In this episode of “Lab Medicine Rounds” this holiday season, Justin Kreuter, M.D., and D. Jane Hata, Ph.D., D(ABMM), Assistant Professor of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, and Associate Director of the Clinical Microbiology Laboratory, including Molecular Virology, Mycology, and Parasitology at Mayo Clinic’s Florida campus, discuss responding with grace while under pressure.

With the omicron variant grabbing headlines around the world, media outlets have turned to experts like Dr. Binnicker to help clarify the effect this new variant could have and what it might mean for the COVID-19 pandemic.

In a recent Wall Street Journal article, the director of Mayo Clinic’s Infectious Diseases Serology Laboratory, Elitza Theel, Ph.D., was among a group of experts discussing the value of COVID-19 antibody testing.

The NIH has awarded $40 million to Mayo Clinic to develop a comprehensive biorepository as the source of clinical samples for long COVID research studies.

Representing Mayo Clinic at the event, Dr. William Morice contributed his expertise and experience as leaders from around the world redoubled their commitment to end the COVID-19 pandemic.

Director of Mayo Clinic’s Infectious Diseases Serology Laboratory, Elitza Theel, Ph.D., joins a discussion about COVID-19 antibody testing in a recent story on NPR.

Personalized medicine represents unprecedented potential benefits for patients. LabConnect and Mayo Clinic BioPharma Diagnostics are working together to bring world-class laboratory testing and resources to industry partners conducting clinical research and trials.